Precision Medicine in Bariatric Procedures
The prevalence of obesity in the United States is greater than 40% currently and is estimated
to reach nearly 50% by 2030. 1, 2 This enormous burden of the disease leads to a heavy …
to reach nearly 50% by 2030. 1, 2 This enormous burden of the disease leads to a heavy …
Type-2 diabetes mellitus remission prediction models after Roux-En-Y gastric bypass and sleeve gastrectomy based on disease severity scores
Aim Metabolic and bariatric surgery (MBS) is considered one of the most effective
interventions for weight loss and associated type-2 diabetes mellitus (T2DM) remission …
interventions for weight loss and associated type-2 diabetes mellitus (T2DM) remission …
[HTML][HTML] Mechanism of action and selection of endoscopic bariatric therapies for treatment of obesity
Endoscopic bariatric therapies (EBTs) are minimally invasive and safe procedures with
favorable weight loss outcomes in obesity treatment. We aimed to present the weight loss …
favorable weight loss outcomes in obesity treatment. We aimed to present the weight loss …
Cumulative effect of obesity phenotypes on body weight and body mass index
Background Obesity originates from an imbalance between energy intake and expenditure.
Changes in energy intake components (satiation, postprandial satiety, emotional eating) and …
Changes in energy intake components (satiation, postprandial satiety, emotional eating) and …
The association between previous use of anti‐obesity medication and semaglutide weight loss outcomes
Aims To compare weight loss outcomes between patients starting semaglutide who had
previously been on another anti‐obesity medication (AOM) compared to those who were …
previously been on another anti‐obesity medication (AOM) compared to those who were …